Toxoplasmosis of the central nervous systems after allogeneic stem cell transplantation
Authors:
Michaela Pevná 1; Petr Vondráček 3; Ivo Palásek 1; Miloš Keřkovský 2
; Zdeněk Kořístek 1; Milan Navrátil 1; Martin Klabusay 1
Authors place of work:
Masarykova univerzita v Brně, Lékařská fakulta, Interní hematoonkologická klinika FN
1; Masarykova univerzita v Brně, Lékařská fakulta, Radiologická klinika FN
2; Masarykova univerzita v Brně, Lékařská fakulta, Klinika dětské neurologie FN
3
Published in the journal:
Čas. Lék. čes. 2010; 149: 184-188
Category:
Case Report
Summary
Toxoplasmosis is a rare opportunistic protozoal infection, which may occur in patients after hematopoietic stem cell transplantation. This disease originates almost exclusively from reactivation of latent infection in seropositive recipients. We present a case report of one patient with diagnosis of acute myeloid leukemia undergoing two allogeneic stem cell transplantations at two years interval. The second transplantation was complicated by the development of the toxoplasmic encephalitis in early posttransplant course. The initial neurological symptoms included diplopia caused by the paresis of right side motor branches of the 3rd and 6th cranial nerves due to a compressive lesion in basal ganglia. Patient suddenly deteriorated after an epileptic seizure followed by a loss of consciousness, bilateral ptosis and right side mydriasis. Prolonged sopor and bilateral mydriasis appeared because of the further lesion progression in basal ganglia and compression of the 3rd cranial nerve. After targeted therapy of Toxoplasma gondii the patient’s clinical status improved and she regained consciousness. Unfortunately, examination of bone marrow later revealed the relapse of leukemia. We compared risk factors of the latent reactivation of infection in immunocompromised patients with published data. It is of interest that the toxoplasmosis of the brain developed in this patient after the second transplantation.
Key words:
toxoplasmosis, encephalitis, brain toxoplasmosis, focal CNS affections, hematopoietic stem cell transplantation.
Zdroje
1. Hegab SM, Al-Mutawa SA. Immunopathogenesis of toxoplasmosis. Clin Exp Med 2003; 3: 84–105.
2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965–1976.
3. Slavin MA, Meyers JD, Remington JS, et al. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994; 13: 549–557.
4. Martino R, Bretagne S, Rovira M, et al. Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2000; 25: 1111–1114.
5. Hejlíček K, Literák I, Vostalová E, et al. Protilátky proti Toxoplasma gondii u gravidních žen v okrese České Budějovice. Epidemiol Mikrobiol Imunol 1999; 48: 102–105.
6. Studeničová C, Ondriska F, Holková R. Séroprevalencia Toxoplasma gondii u gravidných žien na Slovensku. Epidemiol. Mikrobiol Imunol 2008; 57: 8–13.
7. Small TN, Leung L, Kiehn TE, et al. Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation. Bone Marrow Transplant 2000; 25: 969–973.
8. Matsuo Y, Takeishi S, Miyamoto T, et al. Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 year experience in Fukuoka BMT group. Eur J Haematol 2007; 79: 317–321.
9. Belanger F, Derouin F, Grangeot-Keros L, et al. Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988–1995. Clin Infect Dis 1999; 28: 575–581.
10. Mele A, Paterson PJ, Prentice HG, et al. Toxoplasmosis in bone marrow transplantation: a report of two cases and systemic review of the literature. Bone Marrow Transplant 2002; 29: 691–698.
11. Martino R, Maertens J, Bretagne S, et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000; 31: 1188–1194.
12. Janitschke K, Held T, Krüger D, et al. Diagnostic value of tests for Toxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantation. Clin Lab 2003; 49: 239–242.
13. Maury S, Mary JY, Rabian C, et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 2001; 115: 630–641.
14. Girard PM, Landman R, Gaudebout C, et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993; 328: 1514–1520.
15. Chandrasekar PH, Momin F, et al. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant 1997; 19: 685–689.
16. Khoury H, Adkins D, Brown R, et al. Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection. Bone Marrow Transplant 1999; 23: 409–411.
17. Smrcka M, Mrlian A, Karlsson-Valik J, et al. The effect of head injury upon the immune system. Bratisl Lek Listy 2007; 108: 144–148.
18. Chang KH, Han MH. MRI of CNS parasitic diseases. JMRI 1998; 8: 297–307.
19. Maschke M, Dietrich U, Prumbaum M, et al. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant 1999; 23: 1167–1176.
20. Ionita C, Wasay M, Balos L, et al. MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. Am J Neuroradiol, 2004; 25: 270–273.
21. Mueller-Mang C, Mang TG, Kalhs P, et al. Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature. Neuroradiology 2006; 48: 84–89.
22. Bleggi-Torres LF, De Medeiros BC, Werner B, et al. Unusual presentation of cerebral toxoplasmosis after BMT. Bone Marrow Tranplant 1999; 23: 855–856.
23. Picardi M, De Rosa G, Di Salle F, et al. Post-transplant cerebral toxoplasmosis diagnosed by megnetic resonance imaging. Haematologica 1998; 83: 570–572.
24. Dietrich U, Maschke M, Dorfler A, et al. MRI of intracranial toxoplasmosis after bone marrow transplantation. Neuroradiology 2000; 42: 14–18.
25. Bretagne S, Costa JM, Foulet F, et al. Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients. Transpl Infect Dis 2000; 2: 127–132.
26. Cibickova L, Horacek J, Prasil P, et al. Cerebral toxoplasmosis in an allogeneic peripheral stem cell transplant recipient: case report and review of literature. Transpl Infect Dis 2007; 9: 332–335.
27. Brinkman K, Debast S, Sauerwein R, et al. Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21: 635–636.
28. Katlama C, De Wit S, O’Doherty E, et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1996; 22: 268–275.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Plasma citrulline concentration – a reliable noninvasive marker of functional enterocyte mass
- Inflammatory bowel disease and pregnancy
- Cancer multiplicities in the Czech population
- Examination of exhaled breath condensate in cystic fibrosis